← Back to Search

Multifocal Contact Lenses

LID210464, then AOHG MF for Presbyopia

N/A
Waitlist Available
Research Sponsored by Alcon Research
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 30, each wear period. a wear period was approximately 30 days.
Awards & highlights

Study Summary

The primary objective of this study is to demonstrate noninferiority in visual acuity at distance when wearing the test contact lenses (LID210464) compared to the control contact lenses (AOHG MF) after 30 days of wear.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 30, each wear period. a wear period was approximately 30 days.
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 30, each wear period. a wear period was approximately 30 days. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Least Squares Mean Binocular High Contrast/High Illumination Visual Acuity at Distance With Study Lenses

Trial Design

2Treatment groups
Experimental Treatment
Group I: LID210464, then AOHG MFExperimental Treatment3 Interventions
Lehfilcon A multifocal contact lenses (LID210464) worn in Period 1, with lotrafilcon B multifocal contact lenses (AOHG MF) worn in Period 2, as randomized. Each study lens type will be worn bilaterally (in both eyes) for 30 days. CLEAR CARE® will be used for nightly contact lens cleaning and disinfecting.
Group II: AOHG MF, then LID210464Experimental Treatment3 Interventions
Lotrafilcon B multifocal contact lenses (AOHG MF) worn in Period 1, with lehfilcon A multifocal contact lenses (LID210464) worn in Period 2, as randomized. Each study lens type will be worn bilaterally (in both eyes) for 30 days. CLEAR CARE® will be used for nightly contact lens cleaning and disinfecting.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
CLEAR CARE®
2022
N/A
~110
Lehfilcon A multifocal contact lenses
2022
N/A
~140
Lotrafilcon B multifocal contact lenses
2022
N/A
~630

Find a Location

Who is running the clinical trial?

Alcon ResearchLead Sponsor
704 Previous Clinical Trials
124,410 Total Patients Enrolled
30 Trials studying Presbyopia
5,627 Patients Enrolled for Presbyopia
Clinical Trial Lead, Vision CareStudy DirectorAlcon Research, LLC
20 Previous Clinical Trials
2,863 Total Patients Enrolled
2 Trials studying Presbyopia
226 Patients Enrolled for Presbyopia

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Clinical Performance Evaluation of Two Frequent Replacement Silicone Hydrogel Multifocal Contact Lenses
2022. "Clinical Performance Evaluation of Two Frequent Replacement Silicone Hydrogel Multifocal Contact Lenses". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05338333.
~36 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top